Advanced Environmental Controlled Release Solutions
From Idea Conceptualization to Product Development & Commercial Realization
GearJump started with the simple idea of developing technology platforms capable of improving the way Active Ingredients are delivered into the environment.
We develop the next generation of advanced controlled release solutions that maximize efficacy and significantly reduce environmental toxicity.
Our vision is to focus on big social impact globally by leveraging breakthrough controlled delivery technologies for the fields of public health, agriculture and animal protection. We strive to introduce disruptive technologies to reduce the burden of vector-borne diseases and agricultural vectors.
Our delivery platforms operate at various scales from nanoparticles to wearable and field use devices for household and agriculture applications and further up to UAV applications.
GearJump Technologies has a problem-centric approach in designing disruptive technologies based on fundamental science:
We first identify the need, and then focus on the fundamental physics and materials science to bring about unique, innovative solutions that address the real core problem.
We research end users' usages, as well as their economies of scale to provide cost-effective, scalable products.
GearJump works with research and industry leaders, and has received support from multiple government agencies, and non-for-profit organizations in the fields of Public Health, Vector Control, AgTech. We are currently running several trials across the globe, including: North America, Latin America, Africa, South East Asia, and Australia.
GearJump develops controlled release platforms to solve big problems.
We develop controlled release devices for vector control to reduce the spread of mosquito-borne diseases that affect millions of people worldwide, including: malaria, dengue, zika.
We also develop controlled release formulations based on nanoparticles and microparticles for the fields of vector control, personal and animal protection, agriculture, aiming to maximize efficacy and dramatically decrease toxicity.
Our product development is core-fundamental. The process flow starts with the idea conceptualization, design quantification, numerical simulations based on Computational Fluid Dynamics (CFD), prototyping, in-vitro and in vivo trials, field trials, product manufacturing and packaging, regulatory process and product registration.
UNPARALLELED TECHNOLOGY PLATFORMS
The Possibilities Are Endless
GearJump has developed unique controlled release technology platforms at various scales. 1. Nano/Microparticle-based AIs. 2. RNAi-based AIs. 3. Next Generation of Spatial Repellents based on Spray Delivery. 4. Controlled Release Devices (CRDs) for personal and field use. 5. UAV-based Delivery System.
MEET THE TEAM
NOEL ELMAN, PHD
CEO & Founder
Noel founded GearJump Technologies, and is in charge of strategy and execution. He brings in over 20 years of management of high tech businesses. Awards received include: GCE via Gates Foundation, DoD, USDA, US Army, US Navy. Prior to this position, he was distinguished member of the technical staff at Draper Laboratory and Research Scientist and Principal Investigator at MIT. Noel was also named Innovation Fellow at the Center For Innovations in Care Delivery at the Massachusetts General Hospital, affiliated with the Harvard Medical School. He performed post-doctoral studies at MIT, received his PhD at Tel-Aviv University, and Master's and Bachelor’s degrees from Cornell University. He has presented 100+ abstracts/papers in journals and conferences. Noel has been a Scientist-in-Residence at San Francisco Science, a technology incubator, accelerator and commercialization hub. Noel is also an adjunct professor in the Department of Innovation at Buenos Aires Institute of Technology. Noel holds several collaborations with leading universities and research institutions around the globe.
PABLO GURMAN, MD
Pablo is responsible for advice on regulatory compliance of new projects, including trials at multiple locations around the world, including: Africa, South America and South East Asia. He is also responsible on providing advice on product registration. He brings in over a decade of experience in R&D. He was a research scientist at University of Texas-Dallas and at Argonne National Laboratory. In addition, he worked in South America in the field of public health in various clinical settings for over 10 years. He received his MD degree with distinction from University of Buenos Aires, and published +40 papers/abstracts/patents/proceedings.
FRANK ALEXIS, PHD
Chief Scientific Officer
Frank is responsible for the science behind new projects related to controlled release solutions. He brings in over 15 years of R&D experience and advanced project execution in the fields of formulation, nano- and micro-technology, as well as controlled release devices. Frank received his B.S. and M.S. from the Technological University of Montpellier, and PhD degree from Nanyang Technological University, Singapore; performed postdoctoral studies a MIT and Harvard Medical School. In addition, Frank received tenure in the Department of Bioengineering at Clemson University, where he is still affiliated as an associate professor and a visiting associate professor at the School of Chemical and Biomedical Engineering at Nanyang Technological University. He holds 6 US and foreign patents licensed to industry and was listed in Nature Biotechnology as Top Translational Junior Faculty in 2013, and presented 100+ abstracts/papers in international journals and conferences.
RAANAN MILLER, PHD
Chief Strategy and Technology Officer
Raanan is responsible for execution of advanced engineering projects related to novel approaches for controlled release solutions. He brings in over 20 years of executive and R&D experience, as well as founding several high tech companies. Raanan has held many academic positions, including executive director of the MIT Energy Initiative Utility of the Future study. He also worked in strategy and business development at Draper Laboratory, and as Vice President of Business Development at Global Prior Art. As a leader in energy, life sciences and innovation, Miller accompanied former Massachusetts Governor Deval Patrick on his a trade mission to Israel and the United Kingdom in 2011. Raanan was also founder of Sionex Corporation, a venture capital-backed manufacturer of trace chemical detection systems for the industrial, energy, environmental, and homeland security markets. He received his PhD and MS degrees from the California Institute of Technology (Caltech), and an MBA from the MIT Sloan School of Management, and published +100 papers/abstracts/patents/proceedings.
EVP & CFO
Brett is in charge of executive strategy and finance. He brings in several decades of experience in high tech. An entrepreneurial hands-on operational and financial senior executive with 25 years’ experience and a passion and talent for building and growing businesses, with a strong track record in developing and leading high performing teams, maintaining accountability and developing strong relationships with stakeholders. Key expertise in capital raising, investor relations, reporting and compliance, as well as experience in reporting to Boards and carrying out duties as a Board member.
GERALD SANDERS, JD
Chief Strategy Officer - Board Member
Gerald Sanders is a board member and provides key corporate strategy. He's a member of the New York and California Bar Associations, Jerry is a graduate of Queen’s College (B.A.) and The University of Texas (J.D.), a Post-Graduate Certificant of the Goethe Institute in Bonn, Germany, and a Certificant in Comparative Constitutional Law from the National Autonomous University of Mexico City, Mexico. In addition to managing San Francisco Science, Jerry teaches at Oxford University’s Saïd Business School (where he is an “Associate Fellow”). He is the subject of a popular Harvard Business School case study on entrepreneurship entitled: “The Jerry Sanders Case” and the founder of FASE (The French American Society for Entrepreneurs). He serves as an advisor to The Paris Chamber of Commerce and in that capacity serves also as a member of the Paris Chamber of Commerce/Paris Business School consortia for the globalization of technology development. Jerry is a US State Department accredited Honorary Consul for The Republic of Haiti. Jerry has served as Special Counsel to The Government of Israel; Senior Counsel and Director of Development for Hyatt International Hotels; Business Advisor to leading European companies; President and Chief Operating Officer of the Shaw Medical Technology Group; and Commissioner of the Environment for the City of Sonoma.
HARRY YUKLEA, PHD
Strategic Advisor - Board Member
Harry is a member of the board and strategic advisor. He brings several decades of experience in a unique combination of academic and business management practice at once, being directly involved for the last 40 years in the remarkable build-up process of the Israeli high-tech sector, in positions ranging from technology development and engineering to marketing, management, consulting and investment. His career includes executive management positions at leading publicly traded hi-tech companies, as well as at a series of technology start-ups, and served in the Board of Directors of several high-tech firms. Harry served as advisor to the Israeli National Economic Council, the Israel Innovation Authority and international agencies such as EUREKA (EU), IADB (USA) and iCreate (India). He co-founded recently Quantum China-Israel Investment Ltd, a Chinese firm specialized in creating Israel-China technology joint ventures. On the academic track, Dr. Yuklea serves, in addition to his affiliation with the Technion, the Hebrew University and the Tel Aviv University in Israel, as permanent visiting professor at several foreign universities including TUC Crete, ORTU Montevideo, IITGn and PDPU India where he is teaching graduate courses in his field of academic expertise: Economics of Innovation, Entrepreneurial Finance and Entrepreneurial Policy Design. He is also Academic Director of several programs in Entrepreneurship Formation for Youth in Israel and abroad. He received his MSEE from TUI, a MSM from Boston University and PhD from The Hebrew University of Jerusalem.
Chief Computer Engineering Architect
Jonatan is in charge of execution of advanced projects involving computing, IoT and intelligent controlled release systems. He brings in over 25 years of R&D and management experience. Jonatan co-founded Core Security, a leader in cyber security. He also co-founded a number of high tech ventures, including Satellogic. In addition, he co-founded Aconcagua Ventures, an early stage venture capital firm. He studied mathematics at UBA.
G. Kohn Loncarica, MD
Medical Affairs Advisor
Dr. Guillermo Kohn Loncarica is a strategic advisor for medical innovation in public health. He brings in about 20 years of clinical experience in the field of general pediatrics and pediatric emergency medicine. He provides strategic advice to identify and address clinical needs and integrate technological solutions in developing countries. He is the Clinical Chief of the Division of Emergency Pediatrics at Garrahan Hospital in Argentina, one of the largest children's hospitals in Latin America. He received his MD degree from University of Buenos Aires, and published +20 papers in journals and international proceedings.
MEDIA & PRESS UPDATES
GET IN TOUCH
We’re happy to hear from you. Contact us today to learn more about our business and how you can benefit from working with us.